KLRS
#3960
Kalaris Therapeutics, Inc. - Common Stock
4.4 9 USD
+0.02%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
Range Annuel
Changement quotidien
+1.58%
Changement Mensuel
-1.10%
Evolution sur 6 mois
-56.11%
Changement Annuel
-56.11%
Clôture Précédente
4.4 2
Open
4.4 9
Low
4.4 9
High
4.5 0
Volume
3
Financials
- Market Capitalization 106.83 M
- Employee 20
- Founded 2019
- CEO N/A
- Website www.kalaristx.com
- Headquarter Delaware, United States
- FIGI BBG00P80SH34
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3953 |  BDTX Black Diamond Therapeutics, Inc. - Common Stock | 1.89 USD | -0.53% | -10.85% | +5.00% | -35.93% | 108.30 M USD | ||
| 3957 |  ICCC ImmuCell Corporation - Common Stock | 11.90 USD | +7.40% | +13.44% | +24.09% | +83.93% | 107.66 M USD | ||
| 3973 |  VRCA Verrica Pharmaceuticals Inc. - Common Stock | 6.05 USD | +2.20% | -0.66% | +4.31% | +0.50% | 103.93 M USD | ||
| 3975 |  SPRO Spero Therapeutics, Inc. - Common Stock | 1.79 USD | -17.89% | -17.51% | -38.91% | -31.42% | 103.64 M USD |